Skip to main content
Erschienen in: Journal of General Internal Medicine 2/2008

01.02.2008 | Original Article

Under Utilization of Surveillance Mammography among Older Breast Cancer Survivors

verfasst von: Terry S. Field, DSc, Chyke Doubeni, MD, MPH, Matthew P. Fox, DSc, MPH, Diana S. M. Buist, PhD, Feifei Wei, PhD, Ann M. Geiger, MPH, PhD, Virginia P. Quinn, PhD, Timothy L. Lash, DSc, MPH, Marianne N. Prout, MD, MPH, Marianne Ulcickas Yood, DSc, Floyd J. Frost, PhD, Rebecca A. Silliman, PhD, MD

Erschienen in: Journal of General Internal Medicine | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Annual surveillance mammography is recommended for follow-up of women with a history of breast cancer. We examined surveillance mammography among breast cancer survivors who were enrolled in integrated healthcare systems.

Methods

Women in this study were 65 or older when diagnosed with early stage invasive breast cancer (N = 1,762). We assessed mammography use during 4 years of follow-up, using generalized estimating equations to account for repeated measurements.

Results

Eighty-two percent had mammograms during the first year after treatment; the percentage declined to 68.5% in the fourth year of follow-up. Controlling for age and comorbidity, women who were at higher risk of recurrence by being diagnosed at stage II or receiving breast-conserving surgery (BCS) without radiation therapy were less likely to have yearly mammograms (compared to stage I, odds ratio [OR] for stage IIA 0.72, confidence interval [CI] 0.59, 0.87, OR for stage IIB 0.75, CI 0.57, 1.0; compared to BCS with radiation, OR 0.58, CI 0.43, 0.77). Women with visits to a breast cancer surgeon or oncologist were more likely to receive mammograms (OR for breast cancer surgeon 6.0, CI 4.9, 7.4, OR for oncologist 7.4, CI 6.1, 9.0).

Conclusions

Breast cancer survivors who are at greater risk of recurrence are less likely to receive surveillance mammograms. Women without a visit to an oncologist or breast cancer surgeon during a year have particularly low rates of mammography. Improvements to surveillance care for breast cancer survivors may require active participation by primary care physicians and improvements in cancer survivorship programs by healthcare systems.
Literatur
1.
Zurück zum Zitat Grunfeld E, Noorani H, McGahan L, et al. Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast. 2002;11:228–35.PubMedCrossRef Grunfeld E, Noorani H, McGahan L, et al. Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast. 2002;11:228–35.PubMedCrossRef
2.
Zurück zum Zitat Woodward WA, Strom EA, Tucker SL, et al. Changes in the 2003 American Joint Committee on Cancer Staging for Breast Cancer dramatically affect stage-specific survival. J Clin Oncol. 2003;21:3244–8.PubMedCrossRef Woodward WA, Strom EA, Tucker SL, et al. Changes in the 2003 American Joint Committee on Cancer Staging for Breast Cancer dramatically affect stage-specific survival. J Clin Oncol. 2003;21:3244–8.PubMedCrossRef
3.
Zurück zum Zitat Lash TL, Silliman RA, Guadagnoli E, Mor V. The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer. 2000;89:1739–47.PubMedCrossRef Lash TL, Silliman RA, Guadagnoli E, Mor V. The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer. 2000;89:1739–47.PubMedCrossRef
4.
Zurück zum Zitat Smith BD, Gross CP, Smith GL, et al. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst. 2006;98:681–90.PubMedCrossRef Smith BD, Gross CP, Smith GL, et al. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst. 2006;98:681–90.PubMedCrossRef
5.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.CrossRef Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–717.CrossRef
6.
Zurück zum Zitat Khatcheressian JL, Wolff AC, Smith TH, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–7.PubMedCrossRef Khatcheressian JL, Wolff AC, Smith TH, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–7.PubMedCrossRef
7.
Zurück zum Zitat Schapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Med Care. 2000;38:281–9.PubMedCrossRef Schapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Med Care. 2000;38:281–9.PubMedCrossRef
8.
Zurück zum Zitat Lash TL, Silliman RA. Medical surveillance after breast cancer diagnosis. Med Care. 2001;39:945–55.PubMedCrossRef Lash TL, Silliman RA. Medical surveillance after breast cancer diagnosis. Med Care. 2001;39:945–55.PubMedCrossRef
9.
Zurück zum Zitat Geller BM, Kerlikowske K, Carney PA, et al. Mammography surveillance following breast cancer. Breast Cancer Res Treat. 2003;81:107–15.PubMedCrossRef Geller BM, Kerlikowske K, Carney PA, et al. Mammography surveillance following breast cancer. Breast Cancer Res Treat. 2003;81:107–15.PubMedCrossRef
10.
Zurück zum Zitat Keating NL, Landrum MB, Guadagnoli E, Winer RP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85–94.PubMedCrossRef Keating NL, Landrum MB, Guadagnoli E, Winer RP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85–94.PubMedCrossRef
11.
Zurück zum Zitat Doubeni CA, Field TS, Yood MU, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:2482–8.PubMedCrossRef Doubeni CA, Field TS, Yood MU, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:2482–8.PubMedCrossRef
12.
Zurück zum Zitat Enger SM, Thwin S, Buist DS, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006;24:4377–83.PubMedCrossRef Enger SM, Thwin S, Buist DS, et al. Breast cancer treatment of older women in integrated health care settings. J Clin Oncol. 2006;24:4377–83.PubMedCrossRef
13.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.PubMedCrossRef
14.
Zurück zum Zitat GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA. 1994;271:1587–92.CrossRef GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA. 1994;271:1587–92.CrossRef
15.
Zurück zum Zitat Del Truco M, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA. 1994;271:1593–7.CrossRef Del Truco M, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA. 1994;271:1593–7.CrossRef
16.
Zurück zum Zitat Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. The Lancet. 2002;359:909–19.CrossRef Nystrom L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. The Lancet. 2002;359:909–19.CrossRef
17.
Zurück zum Zitat Samant RS, Olivotto IA, Jackson JSH, Mates D. Diagnosis of metachronous contralateral breast cancer. Breast J. 2001;7:405–10.PubMedCrossRef Samant RS, Olivotto IA, Jackson JSH, Mates D. Diagnosis of metachronous contralateral breast cancer. Breast J. 2001;7:405–10.PubMedCrossRef
18.
Zurück zum Zitat Voogd AC, van Tienhoven G, Peterse HL, et al. Local recurrence after breast conservatioin therapy for early stage breast carcinoma. Cancer. 1999;85:437–46.PubMedCrossRef Voogd AC, van Tienhoven G, Peterse HL, et al. Local recurrence after breast conservatioin therapy for early stage breast carcinoma. Cancer. 1999;85:437–46.PubMedCrossRef
19.
Zurück zum Zitat Lash TL, Clough-Gorr K, Silliman RA. Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy. Breast Cancer Res Treat. 2005;89:61–7.PubMedCrossRef Lash TL, Clough-Gorr K, Silliman RA. Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy. Breast Cancer Res Treat. 2005;89:61–7.PubMedCrossRef
20.
Zurück zum Zitat Geiger AM, Thwin SS, Lash TL, et al. Recurrences and second primary breast cancers in older women with early stage disease initially. Cancer. 2007;109:966–74.PubMedCrossRef Geiger AM, Thwin SS, Lash TL, et al. Recurrences and second primary breast cancers in older women with early stage disease initially. Cancer. 2007;109:966–74.PubMedCrossRef
21.
Zurück zum Zitat Lash TL, Fox MP, Buist DSM, et al. Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol. 2007;25:3001–6.PubMedCrossRef Lash TL, Fox MP, Buist DSM, et al. Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol. 2007;25:3001–6.PubMedCrossRef
22.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E, eds. In: From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: The National Academies; 2006. Hewitt M, Greenfield S, Stovall E, eds. In: From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: The National Academies; 2006.
23.
Zurück zum Zitat Taplin SH, Urban N, Taylor VM, Savarino J. Conflicting national recommendations and the use of screening mammography: does the physician’s recommendation matter? J Am Board Fam Pract. 1997;10:88–95.PubMed Taplin SH, Urban N, Taylor VM, Savarino J. Conflicting national recommendations and the use of screening mammography: does the physician’s recommendation matter? J Am Board Fam Pract. 1997;10:88–95.PubMed
24.
Zurück zum Zitat Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848–55.PubMedCrossRef Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848–55.PubMedCrossRef
25.
Zurück zum Zitat Taplin SH, Ichikawa L, Buist DSM, Seger D, White E. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease. Cancer Epi, Biomarkers & Prev. 2004;13:225–34.CrossRef Taplin SH, Ichikawa L, Buist DSM, Seger D, White E. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease. Cancer Epi, Biomarkers & Prev. 2004;13:225–34.CrossRef
Metadaten
Titel
Under Utilization of Surveillance Mammography among Older Breast Cancer Survivors
verfasst von
Terry S. Field, DSc
Chyke Doubeni, MD, MPH
Matthew P. Fox, DSc, MPH
Diana S. M. Buist, PhD
Feifei Wei, PhD
Ann M. Geiger, MPH, PhD
Virginia P. Quinn, PhD
Timothy L. Lash, DSc, MPH
Marianne N. Prout, MD, MPH
Marianne Ulcickas Yood, DSc
Floyd J. Frost, PhD
Rebecca A. Silliman, PhD, MD
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 2/2008
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0471-2

Weitere Artikel der Ausgabe 2/2008

Journal of General Internal Medicine 2/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.